ÂÜÀòÂÒÂ×

Carter Cliff is Founder & CEO of Vascugen, a company committed to developing treatments for patients suffering from incurable diseases including the leading cause of limb amputation. Previously he co-founded Opsis Therapeutics with the goal to reverse blinding disorders of the retina, which led to a Strategic R&D Alliance with BlueRock Therapeutics. A serial entrepreneur, Carter co-founded RPRD Diagnostics to market ethnicity-inclusive precision medicine.